ADST Technologies

Mass Injection Devices

Health Tech & Life Sciences
Non Active, May 2022 ceased to operate

Company Overview

Snapshot

Founded in September 2013 by Shaul Wolfstein, ADST Technologies operated with 1–10 employees. The company developed medical devices for mass vaccination, but ceased operations in May 2022.

Business overview

ADST Technologies developed an automated, safe, and sterile device for mass vaccination, designed to prevent the spread of disease. Its core product is a disposable syringe device that automatically replaces the needle after each injection, ensuring sterility and eliminating reuse. The device also features an internal disinfection mode and meets IP65 standards for external sterilization. The company served markets within Health Tech & Life Sciences, specifically focusing on medical equipment and vaccines for clinics, hospitals, and veterinary applications, including livestock.

Company Intelligence Q&A

What is ADST Technologies' primary product?
ADST Technologies developed an automated, safe, and sterile disposable syringe device for mass vaccination, designed to prevent disease transmission by automatically replacing the needle after each use.
When was ADST Technologies founded?
ADST Technologies was founded in September 2013.
Who is a co-founder of ADST Technologies?
Shaul Wolfstein is a co-founder of ADST Technologies.
What is the operational status of ADST Technologies?
ADST Technologies is non-active and ceased to operate in May 2022.
Which sectors did ADST Technologies operate in?
ADST Technologies operated in the Health Tech & Life Sciences sector, focusing on medical devices, public health, animal health, and agriculture.